Editorial: Immune Landscape of Kidney Pathology

Frontiers in Physiology

Patrick Ming-Kuen Tang¹  David J. Nikolic-Paterson³  Ying Tang⁵  Hui Yao Lan⁶  Haiyong Chen⁷ 

[1] Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China;Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China;Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia;Department of Nephrology, Monash University, Clayton, VIC, Australia;Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China;Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China;School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China;

关键词: inflammation;    fibrosis;    immunity;    therapy;    lncRNA;    macrophage-myofibroblast transition;   

DOI  :  10.3389/fphys.2021.827537

来源: DOAJ

【 授权许可】

Unknown